TESTING 2.0 in Kidney Medicine

The NephJC editorial in Kidney Medicine is live. Great work from Anand Chellapan and Rachael Kermond, supported by Tiffany, Jade and Swap. Read it here.

With a bonus table which already needs updating post EMPAKIDNEY!

The STOP ACEi Trial - Visual Abstract

Does the discontinuation of RAS inhibitors improve eGFR in patients with advanced CKD? NSMC Intern Dana Larsen explains it graphically.

View fullsize

Flozins strike again!

If you missed the biggest NephJC of the year, at least read the highlights here.

If you only read one #TenTweetNephJC this year, make it this one.

EMPA-KIDNEY is one of those landmark trials it is worth knowing inside-out, but you can still rapidly catch up on the key findings & author tweetchat secrets in the thread below👇 pic.twitter.com/VL2u8BoCLw

— Nephrology Journal Club (@NephJC) November 22, 2022

The future for refractory lupus nephritis?

Ten Tweet round up of exciting CAR T trial in patients with SLE discussed last month - check it out while you can!

Welcome to #TenTweetNephJC

✳️ 10 tweets #NephJC catch-up ✳️

Here’s a recap of our 25th Oct #NephJC discussion on ‘Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus’ - better late than never!

Check out the paper at https://t.co/HxTcVC3PtH pic.twitter.com/y7o71HUPiZ

— Nephrology Jrnl Club (@NephJC) November 18, 2022

KidneyWk 2022 BINGO

Get the original #KidneyWk Bingo Board here (PDF).
We are not responsible if you get kicked out for yelling “BINGO!”